Express Scripts Holding Company (NASDAQ:ESRX)’ public spat with Walgreen allowed it to exercise its bargaining power, eventually getting the nation’s largest drugstore chain to agree to concessions in its contract renewal. As Express Scripts grows its network, half-hearted competitors like Aetna and Wellpoint have decided to exit the market; the only remaining major competitor is CVS Caremark, which has struggled to integrate its pharmacy benefit management business with its drugstore chain and clinical services. If Express Scripts Holding Company (NASDAQ:ESRX) continues to slay competitors, shareholders will be richly rewarded.
It is impossible to eliminate the risk of loss, but buying high-growth companies at reasonable prices is a good way to limit one’s risk. Visa Inc (NYSE:V), Priceline.com Inc (NASDAQ:PCLN), and Express Scripts Holding Company (NASDAQ:ESRX) offer investors growth for less risk than the overall market.
The article 3 Underrated Growth Stocks to Protect Your Portfolio originally appeared on Fool.com and is written by Ted Cooper.
Ted Cooper has no position in any stocks mentioned. The Motley Fool recommends Express Scripts, Priceline.com, and Visa. The Motley Fool owns shares of Express Scripts, Priceline.com, and Visa.
Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.